Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of repeated intravenous
infusions of EMZ702 in combination with pegylated interferon and ribavirin in patients with
chronic hepatitis C genotype 1.